移植脏中复发的非典型抗质底膜炎
Salvatore E Mignano1, Samih H Nasr1, Mary E Fidler1
1Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
概括
非典型的抗质底膜 (anti-GBM) 炎在脏移植中复发,其特征是没有新月的线性免疫球蛋白染色. 这种复发通常呈现温和,表明与循环单克隆蛋白质的联系.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫病理学 免疫病理学
- 移植免疫学 移植免疫学
背景情况:
- 非典型的抗质底膜 (抗GBM) 炎是由线性GBM染色以检测免疫球蛋白 (Ig) 而没有扩散的半月形图案来定义的.
- 了解移植后非典型抗GBM炎的复发情况对于患者管理至关重要.
研究的目的:
- 描述移植后复发的非典型抗GBM炎的临床病理特征.
- 调查这种罕见并发症的特征和结果.
主要方法:
- 分析了6名患有复发性非典型抗GBM腎炎移植后6名患者的18个活检.
- 免疫光 (IF) 用于质Ig染色 (观察到单型线性模式).
- 淋巴细胞变化的组织学检查和血清抗GBM抗体和单克隆蛋白质的评估.
主要成果:
- 移植后平均3.8个月发生复发,并出现轻微的球组织学变化.
- 异体移植显示出单型的线性球体Ig染色 (IgG卡帕,IgG兰巴,IgA卡帕,IgA兰巴,IgM兰巴).
- 没有发现显著的进展,可检测的血清抗GBM抗体或单克隆蛋白;没有发生移植损失.
结论:
- 单类型的非典型抗GBM炎在移植时复发.
- 这些发现支持了循环单克隆蛋白质是潜在原因的假设.
- 这一系列的复发性疾病没有导致移植损失,这表明在某些情况下的预后可能是有利的.
相关概念视频
Kidney Transplant II: Surgical Procedure
22
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
22
Kidney Transplant III: Nursing Management
23
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
23
Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
Acute Kidney Injury II: Pathophysiology
12
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
12
Renal Corpuscle
2.5K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.5K
Acute Kidney Injury III: Clinical Manifestations
15
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
15


